Paper18281925
Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.
Jones HP and 3 others. Cancer Immun, 2008. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. Papers, record 18281925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18281925
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| B-Lymphocytes | Major topic |
| Immunologic Surveillance | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasms, Experimental | Major topic |
| Spleen | Major topic |
| Animals | |
| B7-1 Antigen | |
| B7-2 Antigen | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Interferon-gamma | |
| Killer Cells, Natural | |
| Lymphocytes, Tumor-Infiltrating | |
| Male | |
| Rats | |
| Rats, Inbred F344 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA087923 | NCI NIH HHS | United States | R01CA087923 | PubMed |
Source NIH RePORTER
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7553886 | B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. | Cell Immunol | 1995 | https://conductscience.org/library/papers/7553886 | PubMed |
| 2 | 8885864 | Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1) | Immunity | 1996 | https://conductscience.org/library/papers/8885864 | PubMed |
| 3 | 12154358 | Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. | Nat Immunol | 2002 | https://conductscience.org/library/papers/12154358 | PubMed |
| 4 | 10354375 | Interaction between B.7 and CD28 costimulatory molecules is essential for the activation of effector function mediating spontaneous tumour regression. | Scand J Immunol | 1999 | https://conductscience.org/library/papers/10354375 | PubMed |
| 5 | 14707050 | Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. | J Immunol | 2004 | https://conductscience.org/library/papers/14707050 | PubMed |
| 6 | 10394132 | Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. | Pathobiology | 1999 | https://conductscience.org/library/papers/10394132 | PubMed |
| 7 | 9010717 | The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. | Immunol Rev | 1996 | https://conductscience.org/library/papers/9010717 | PubMed |
| 8 | 8635191 | Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2. | Cancer Immunol Immunother | 1995 | https://conductscience.org/library/papers/8635191 | PubMed |
| 9 | 12176894 | IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. | Blood | 2002 | https://conductscience.org/library/papers/12176894 | PubMed |
| 10 | 1894371 | Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis. | Infect Immun | 1991 | https://conductscience.org/library/papers/1894371 | PubMed |
| 11 | 7540948 | Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. | Cancer Res | 1995 | https://conductscience.org/library/papers/7540948 | PubMed |
| 12 | 11970991 | A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. | J Immunol | 2002 | https://conductscience.org/library/papers/11970991 | PubMed |
| 13 | 17183544 | Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton. | Cell Motil Cytoskeleton | 2007 | https://conductscience.org/library/papers/17183544 | PubMed |
| 14 | 2492576 | Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma. | J Immunol | 1989 | https://conductscience.org/library/papers/2492576 | PubMed |
| 15 | 11591779 | The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. | J Immunol | 2001 | https://conductscience.org/library/papers/11591779 | PubMed |
| 16 | 16049975 | Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity. | Int J Cancer | 2006 | https://conductscience.org/library/papers/16049975 | PubMed |
| 17 | 9585241 | B cells inhibit induction of T cell-dependent tumor immunity. | Nat Med | 1998 | https://conductscience.org/library/papers/9585241 | PubMed |
| 18 | 12244160 | Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. | J Immunol | 2002 | https://conductscience.org/library/papers/12244160 | PubMed |
| 19 | 12149421 | Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors. | J Leukoc Biol | 2002 | https://conductscience.org/library/papers/12149421 | PubMed |
| 20 | 3871818 | Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. | J Immunol | 1985 | https://conductscience.org/library/papers/3871818 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41285707 | Targeting tumour-infiltrating B cells: mechanisms and advances in cancer therapy. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41285707 | PubMed |
| 41019045 | Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019045 | PubMed |
| 40959278 | Activated B cells modulate the maturation of MDSCs via CD36-dependent MHC-II transfer to orchestrate CD4+ Th1-dominant antitumor immunity after cryo-thermal therapy. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40959278 | PubMed |
| 38391970 | Regulatory B Cells-Immunopathological and Prognostic Potential in Humans. | Cells | 2024 | https://conductscience.org/library/papers/38391970 | PubMed |
| 37215990 | B cells in tumor metastasis: friend or foe? | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37215990 | PubMed |
| 36389757 | Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389757 | PubMed |
| 36175603 | Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer. | Med Oncol | 2022 | https://conductscience.org/library/papers/36175603 | PubMed |
| 35563678 | Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563678 | PubMed |
| 35152302 | Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/35152302 | PubMed |
| 33139907 | Tumor-infiltrating lymphocytes in the immunotherapy era. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33139907 | PubMed |
| 33098370 | Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma. | Cancer Med | 2020 | https://conductscience.org/library/papers/33098370 | PubMed |
| 29628498 | Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer. | Cell Mol Immunol | 2019 | https://conductscience.org/library/papers/29628498 | PubMed |
| 29153616 | A role for B cells in facilitating defense against an NK cell-sensitive lung metastatic tumor is revealed by stress. | J Neuroimmunol | 2017 | https://conductscience.org/library/papers/29153616 | PubMed |
| 28626234 | B cell regulation in cancer and anti-tumor immunity. | Cell Mol Immunol | 2017 | https://conductscience.org/library/papers/28626234 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18281925
GET https://conductscience.org/api/papers/v1/18281925/references?page=2